Literature DB >> 28758625

The dengue virus non-structural protein 1 (NS1) is secreted from infected mosquito cells via a non-classical caveolin-1-dependent pathway.

Ana C Alcalá1,2, Raiza Hernández-Bravo3, Fernando Medina2, David S Coll4, Jose L Zambrano5, Rosa M Del Angel2, Juan E Ludert2.   

Abstract

Dengue virus NS1 is a glycoprotein of 46-50 kDa that is conserved among flaviviruses, associates as a dimer to cell membranes and is secreted as a hexamer to the extracellular milieu. Recent evidence showed that NS1 is secreted efficiently from infected mosquito cells. To explore the secretory route of NS1 in mosquito cells, infected cells were treated with brefeldin A (BFA) and methyl-beta-cyclodextrin (MβCD). The results showed that MβCD, but not BFA, significantly reduced the release of NS1. Moreover, silencing the expression of caveolin-1 (CAV1; a key component of the caveolar system that transports cholesterol inside the cell), but not SAR1 (a GTPase that participates in the classical secretory pathway), also results in a significant reduction of the secretion of NS1. These results indicate that NS1 is released from mosquito cells via an unconventional secretory route that bypasses the Golgi complex, with the participation of CAV1. In agreement with this notion, differences were observed in the glycosylation status between secreted NS1 and E proteins. Classical mechanics and docking simulations suggested highly favoured interactions between the caveolin-binding domain present in NS1 and the scaffolding domain of CAV1. Finally, proximity ligation assays showed direct interaction between NS1 and CAV1 in infected mosquito cells. These findings are in line with the lipoprotein nature of secreted NS1 and provide new insights into the biology of NS1.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28758625     DOI: 10.1099/jgv.0.000881

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

1.  The Dengue Virus Nonstructural Protein 1 (NS1) Is Secreted from Mosquito Cells in Association with the Intracellular Cholesterol Transporter Chaperone Caveolin Complex.

Authors:  Romel Rosales Ramirez; Juan E Ludert
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

2.  The Dengue Virus Nonstructural Protein 1 (NS1) Interacts with the Putative Epigenetic Regulator DIDO1 to Promote Flavivirus Replication in Mosquito Cells.

Authors:  Gerson I Caraballo; Romel Rosales; Mercedes Viettri; Juan Manuel Castillo; Raymundo Cruz; Siyuan Ding; Harry B Greenberg; Juan E Ludert
Journal:  J Virol       Date:  2022-06-02       Impact factor: 6.549

Review 3.  Secretion of Nonstructural Protein 1 of Dengue Virus from Infected Mosquito Cells: Facts and Speculations.

Authors:  Ana C Alcalá; Laura A Palomares; Juan E Ludert
Journal:  J Virol       Date:  2018-06-29       Impact factor: 5.103

Review 4.  Multifaceted Functions of Host Cell Caveolae/Caveolin-1 in Virus Infections.

Authors:  Yifan Xing; Zeyu Wen; Wei Gao; Zhekai Lin; Jin Zhong; Yaming Jiu
Journal:  Viruses       Date:  2020-04-26       Impact factor: 5.048

5.  Combination of the Focus-Forming Assay and Digital Automated Imaging Analysis for the Detection of Dengue and Zika Viral Loads in Cultures and Acute Disease.

Authors:  Sara Bolívar-Marin; Irene Bosch; Carlos F Narváez
Journal:  J Trop Med       Date:  2022-07-19

Review 6.  Cyclodextrins: Emerging Medicines of the New Millennium.

Authors:  Susana Santos Braga
Journal:  Biomolecules       Date:  2019-11-28

7.  Releasing Intracellular NS1 from Mosquito Cells for the Detection of Dengue Virus-Infected Mosquitoes.

Authors:  Lie Cheng; Wei-Liang Liu; Hsing-Han Li; Matthew P Su; Shih-Cheng Wu; Hsin-Wei Chen; Chao-Ying Pan; Jih-Jin Tsai; Chun-Hong Chen
Journal:  Viruses       Date:  2020-09-29       Impact factor: 5.048

Review 8.  Cyclodextrins in Antiviral Therapeutics and Vaccines.

Authors:  Susana Santos Braga; Jéssica S Barbosa; Nádia E Santos; Firas El-Saleh; Filipe A Almeida Paz
Journal:  Pharmaceutics       Date:  2021-03-19       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.